Mark J. Foley

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Aliso Viejo, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Diana Scherer, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark J. Foley

Form 4 holding Director

GLAUKOS Corp

Security class
Stock Option (Right to Buy)
Shares / value
2,987
Estimated value
$0
Report date
28 May 2026
Price
$69.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & CEO, Director

Revance Therapeutics, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
06 Feb 2025
Price
$3.65
Ownership
Direct
Form 4 holding President & CEO, Director

Revance Therapeutics, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
04 Feb 2025
Price
$3.65
Ownership
Indirect

Insider Reports Filed by Mark J. Foley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .